Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

Michael Clayman Net Worth & Insider Trades

Michael Clayman - President and CEO, Flexion Therapeutics Inc

As of November 19, 2021

What is Michael Clayman's Net Worth?

The current estimated net worth of Flexion Therapeutics Inc's President and CEO, Michael Clayman, is estimated to be about $40.52K . Michael Clayman owns about 735,288 units of Flexion Therapeutics Inc common stock. In the last 7 years at Flexion Therapeutics Inc, Michael Clayman has sold an estimated value of $10.04M worth.

What is Michael Clayman's Past Insider Trading?

Michael Clayman's largest purchase order was 10,000 units , worth over $223.3K on August 10, 2018. Michael Clayman's largest sale order was 3,278 units , worth over $40.52K on January 4, 2019. In total, Michael Clayman has made about 42 transactions over 7 years of their time at Flexion Therapeutics Inc. Michael Clayman usually trades in May, with the busiest year in 2016. The most recent transaction was a purchase order of 10,256 units , worth over $100K on May 27, 2020.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Michael Clayman

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Michael Clayman's' Mailing Address?

  • Mailing address is C/o Flexion Therapeutics, Inc. 10 Mall Road, Suite 301 Burlington MA 01803 MA

What are Flexion Therapeutics Inc's Past Insider Trades?

Flexion Therapeutics Inc's most recent insider trade came on July 20, 2021 by Christina Willwerth who sold 3,945 units worth $25.45K . In the last 7 years, insiders at Flexion Therapeutics Inc have sold an estimated value of $36.93M and bought an estimated value of $69.1M worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are Michael Clayman, President and CEO,  Neil Bodick, Chief Scientific Officer,  and Samuel Colella, Director .

Flexion Therapeutics Inc Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...